Tislelizumab trials for Colorectal cancer

All Tislelizumab trials · All Colorectal cancer trials

Phase breakdown

Recruiting trials studying Tislelizumab for Colorectal cancer

• A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
  NCT07244705 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• Adjuvant PD-1 Blockade for High-risk Stage-II DMMR/MSI-H Colorectal Cancer
  NCT06520683 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
  NCT06848465 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations
• Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer
  NCT06017583 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments
  NCT07468071 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 20 locations
• Tislelizumab in People With Colorectal Cancer
  NCT06529523 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.
  NCT06940388 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Vitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients
  NCT05771181 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Tislelizumab for Colorectal cancer?

8 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.